Restore energy
at the cellular level.
NAD+ is foundational to every cell in your body. As levels decline with age, so does your energy, clarity, and resilience. Luma's clinical-grade NAD+ protocols restore what aging depletes — physician-guided from first dose.
Why NAD+ is the molecule aging researchers can't ignore
NAD+ sits at the intersection of energy metabolism, DNA integrity, and cellular longevity — making it one of the most clinically significant targets in modern anti-aging medicine.
Cellular Energy Production
NAD+ is a required cofactor in the mitochondrial electron transport chain — the process that converts nutrients into ATP, your body's energy currency. Declining NAD+ means declining cellular energy capacity, manifesting as persistent fatigue that no amount of sleep resolves.
DNA Repair & Sirtuins
NAD+ is the essential substrate for sirtuin enzymes — the proteins that regulate DNA repair, gene expression, and cellular stress response. Sirtuins are often called "longevity genes," and they cannot function without adequate NAD+. Clinical replenishment supports your body's native repair mechanisms.
Cognitive Clarity
The brain is one of the most metabolically demanding organs in the body. NAD+ supports neuronal energy metabolism and protects against oxidative stress — two mechanisms closely linked to cognitive performance. Patients report improvements in focus, mental clarity, and memory recall.
Inflammation Modulation
Sherry's clinical background in allergy and immunology gives Luma a unique lens on NAD+: emerging evidence shows it plays a role in modulating inflammatory pathways — including NF-κB signaling — that drive chronic disease and accelerated aging. For patients with inflammatory conditions, this intersection is clinically significant.
The Decline
NAD+ levels drop ~50% by age 60.
The decline begins in your 30s and accelerates through midlife — roughly 1–2% per year. By the time most patients seek answers for persistent fatigue or brain fog, their cellular NAD+ levels may be severely depleted. Oral supplementation has limited bioavailability; Luma's clinical-grade IV and injection protocols bypass the digestive system entirely for direct cellular delivery.
NAD+ replenishment therapy is not FDA-cleared for disease treatment. Clinical observations are based on emerging research and provider-reported outcomes. Individual responses vary.
Longevity through
the lens of
inflammation science.
Sherry Housley spent three decades at the intersection of allergy, immunology, and chronic inflammatory disease. What she discovered: cellular dysfunction and inflammation are two sides of the same coin.
NAD+ therapy at Luma isn't a wellness trend. It's a clinically informed protocol designed by a provider who understands the biochemistry — and knows how to position it within a comprehensive anti-aging framework.
30+
Years clinical practice
NP-C
Board certified
IV + SQ
Delivery options
3
Service pillars
Clinical Director
Sherry Housley, NP-C
Clinical-grade NAD+ delivery
Luma offers two clinically validated delivery methods for NAD+ therapy. Your provider will determine which protocol fits your health profile, goals, and lifestyle.
IV Infusion Protocol
Intravenous NAD+ delivers the coenzyme directly into the bloodstream, bypassing all digestive processing for immediate cellular availability. IV infusions typically run 2–4 hours depending on dosing and tolerance. Most patients report an energy shift within 24–48 hours of their first session.
- Direct bloodstream delivery — 100% bioavailability
- Physician-determined dosing (250mg–1,000mg)
- Administered in a clinical setting
- Recommended series: 4–6 sessions for initial protocol
Subcutaneous Injection Protocol
Subcutaneous NAD+ injections offer a flexible maintenance option for established patients — administered at home after initial training, or in-office. SQ protocols are ideal for patients maintaining NAD+ levels between IV infusion series or who prefer a less time-intensive ongoing cadence.
- Home-administration after provider training
- Flexible dosing schedule (weekly to biweekly)
- Ideal for maintenance post-IV protocol
- All supplies provided by Luma
Is NAD+ therapy right for you?
NAD+ therapy is not a supplement — it's a clinical protocol. Luma works with patients who have specific, medically relevant goals and a commitment to physician-guided care.
Persistent Fatigue
Energy that doesn't respond to sleep, nutrition, or lifestyle changes — often a marker of mitochondrial dysfunction and depleted NAD+.
Cognitive Decline
Brain fog, difficulty concentrating, or memory changes that correlate with aging or high inflammatory burden.
Inflammation-Driven Conditions
Patients with autoimmune, allergic, or chronic inflammatory conditions who want to address root cellular drivers.
Athletic Recovery
Competitive athletes and active individuals seeking to optimize mitochondrial output and accelerate recovery between training cycles.
Longevity Focus
Adults over 35 proactively addressing the cellular changes associated with biological aging before symptoms become significant.
Post-Treatment Recovery
Patients recovering from chemotherapy, illness, or major medical treatment where cellular energy and repair mechanisms need support.
Clinical Honesty
NAD+ therapy is not a cure-all and is not appropriate for all patients. Sherry's clinical assessment will determine whether you are a candidate — and if not, she will direct you toward the appropriate care pathway. We don't sell protocols to patients who won't benefit from them.
Your path to NAD+ therapy
Every Luma patient starts with a clinical assessment. No protocol begins without provider clearance.
Complete the Health Quiz
A 5-minute questionnaire covering your energy, cognitive health, inflammatory history, and goals. Your answers go directly to Sherry's clinical team for review.
Virtual Consultation
Sherry reviews your profile and meets with you via secure video. She'll assess candidacy, recommend an appropriate protocol, and discuss realistic expectations.
Protocol Begins
Your first infusion session is scheduled, or your injection protocol is confirmed with delivery. Ongoing clinical monitoring and dosage adjustment are included.
Start Today — It Takes 5 Minutes
Is NAD+ therapy the
missing piece?
Complete our short health questionnaire. Sherry's team will review your profile and determine whether NAD+ therapy is a clinical fit for your goals. No commitment. No hard sell.
HIPAA-compliant · No credit card required · Results reviewed by a real provider
Frequently asked
Clear answers to common questions about NAD+ therapy at Luma.
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell of the body, essential for energy production, DNA repair, and cellular signaling. Research shows NAD+ levels decline by up to 50% between the ages of 40 and 60, contributing to fatigue, cognitive changes, and accelerated cellular aging. Replenishment through clinical-grade IV or injection therapy bypasses the digestive system for maximum cellular uptake.
Yes. Every protocol at Luma is designed and supervised by Sherry Housley, a board-certified Nurse Practitioner with 30+ years of clinical experience in allergy, immunology, and inflammation. NAD+ therapy is always preceded by a clinical assessment to ensure safety and appropriate dosing.
Clinical observations and emerging research point to improvements in energy levels, mental clarity, sleep quality, and recovery time. Sherry's patients frequently report reduced brain fog and improved stamina within weeks of beginning a structured protocol. We never make specific performance guarantees — individual responses vary based on health history and baseline NAD+ status.
Luma offers clinical-grade NAD+ via IV infusion and subcutaneous injection protocols, depending on your clinical profile and goals. IV administration delivers NAD+ directly to the bloodstream for immediate cellular availability. Your provider will recommend the appropriate delivery method during your consultation.
Candidates typically include adults experiencing persistent fatigue, cognitive decline, accelerated aging markers, or those seeking evidence-informed longevity support. Patients with inflammatory conditions may benefit from NAD+'s anti-inflammatory properties. A clinical assessment with Sherry is required before any protocol begins.
NAD+ has a well-established safety profile with decades of research supporting its clinical use. Luma's protocols are physician-supervised with appropriate dosing and monitoring. Some patients experience mild flushing or nausea during IV infusion, which is typically managed by adjusting the infusion rate. All patients undergo clinical screening prior to treatment.
Complete our short health questionnaire — it takes about 5 minutes and helps Sherry's team understand your health history, goals, and whether NAD+ therapy is a clinical fit. From there, we'll schedule a virtual consultation to design your personalized protocol.
Luma positions NAD+ therapy within a broader longevity and cellular health framework. Sherry approaches anti-aging through the lens of inflammation biology — addressing the cellular mechanisms that drive accelerated aging, not just surface symptoms. NAD+ is one tool in a clinically integrated approach.
Still have questions? Talk to a real provider.
Book a Free ConsultationReady to restore energy at the cellular level?
Physician-guided NAD+ protocols. Clinical-grade delivery. Real oversight.